To determine whether pancreatic cancer is sensitive to pharmacological inhibition of Mgat5, we treated mice bearing T cell–inflamed 2838c3 WT tumors with either swainsonine (1 mg/kg or 4 mg/kg) or vehicle control for 2 weeks. Here, MGAT5 is linked to pancreatic neoplasm.